BioIntelScan aggregates enforcement actions from FDA, FTC, CBER, OPDP, SEC, state attorneys general, and DOJ into a single terminal with real-time compliance scoring for regenerative medicine.
Real-time stream of warning letters, consent decrees, and regulatory actions across all seven agencies. Filterable by operator, jurisdiction, and violation type.
Paste any product description or marketing claim. Get an instant compliance assessment against 21 CFR 1271.10(a) with risk scoring and enforcement precedent citations.
Ranked database of regenerative medicine operators with composite Enforcement Risk Scores derived from warning letter history, violation patterns, and regulatory exposure.
Batch-submit marketing claims for regulatory assessment before your campaign goes live. Reduce enforcement exposure before the first ad runs.
BioIntelScan was built by operators who navigate regenerative medicine compliance every day. Not consultants guessing from the outside. Practitioners building for practitioners.